A comparative analysis of deferoxamine treatment modalities for dermal radiation‐induced fibrosis

The iron chelator, deferoxamine (DFO), has been shown to potentially improve dermal radiation‐induced fibrosis (RIF) in mice through increased angiogenesis and reduced oxidative damage. This preclinical study evaluated the efficacy of two DFO administration modalities, transdermal delivery and direc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavin, Christopher V., Abbas, Darren B., Fahy, Evan J., Lee, Daniel K., Griffin, Michelle, Diaz Deleon, Nestor M., Mascharak, Shamik, Chen, Kellen, Momeni, Arash, Gurtner, Geoffrey C., Longaker, Michael T., Wan, Derrick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572785/
https://www.ncbi.nlm.nih.gov/pubmed/34612609
http://dx.doi.org/10.1111/jcmm.16913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572785/
https://www.ncbi.nlm.nih.gov/pubmed/34612609
http://dx.doi.org/10.1111/jcmm.16913

Ejemplares similares